Editorial Board

Elaine M. Hylek, MD, MPH

Elaine M. Hylek, MD, MPH received her MD from the University of Pittsburgh School Of Medicine and a Masters in quantitative methods in Public Health from Harvard University School of Public Health. Dr. Hylek completed her residency training in internal medical at Massachusetts General Hospital and Harvard Medical School in Boston, Massachusetts. While at Massachusetts General Hospital, Dr. Hylek directed the Medical Consultation Service, served as a Director of the Anticoagulation Management Service, and spearheaded a hospital-wide initiative to standardize indication and use of antithrombotic therapy across the surgical and medical services using the American College of Chest Physicians Antithrombotic Guidelines. Most recently, Dr. Hylek participated in the ACCP-convened workgroup on Grading in Developing Clinical Practice Guidelines. Dr. Hylek is currently a clinical investigator, epidemiologist, and Associate Professor of Medicine at Boston University School of Medicine and practicing internist at Boston Medical Center.

Dr. Hylek's work has helped to define the therapeutic index of warfarin for stroke prevention in atrial fibrillation, risk factors for intracranial hemorrhage on anticoagulant therapy, the association between acetaminophen and warfarin, and predictors of INR normalization following supratherapeutic levels of anticoagulation. Her research interests also include novel risk factors for thrombus formation in atrial fibrillation, and optimizing the safety of antithrombotic therapy in the geriatric population.

Dr. Hylek is on the Editorial Board of Thrombosis Research, and has served as a reviewer for numerous journals including the New England Journal of Medicine, Circulation, JAMA, Annals of Internal Medicine. She serves on the Abstract Grading Panel for the Scientific Sessions Program of the American Heart Association and was among the invited Faculty for the ACCP Consensus Conference on Antithrombotic and Thrombolytic Therapy. Dr. Hylek is a member of the Thrombosis Quorum and several societies, including the American College of Physicians, and the American Heart Association Scientific Councils on Stroke; Arteriosclerosis, Thrombosis, and Vascular Biology; and Epidemiology and Prevention.

Editorial Board Members

• Henry I. Bussey, Pharm.D., FCCP, FAHA -- San Antonio, TX
• Marie B. Walker, BBA -- Fresno, CA & San Antonio, TX
• Mary Amato, Pharm.D., MPH -- Boston, MA
• Jack E. Ansell, M.D. -- Boston, MA
• William E. Dager, Pharm.D., FCSHP -- Sacramento, CA
• Susan C. Fagan, Pharm.D., BCPS, FCCP -- Augusta, GA
• Samuel Z. Goldhaber, M.D. -- Boston, MA
• James B. Groce III, Pharm.D., CACP -- Greensboro, NC
• Stuart T. Haines, Pharm.D., FCCP, FASHP, FAPhA -- W. Palm Beach, FL
• David W. Hawkins, Pharm.D. -- Sacramento, CA
• Elaine M. Hylek, MD, MPH -- Boston, MA
• Roger M. Lyons, MD, FACP -- San Antonio, TX
• Ruth Morrison, R.N., B.S.N., C.V.N. -- Boston, MA
• Edith A. Nutescu, Pharm.D. -- Chicago, IL
• Sarah A. Spinler, PharmD, FCCP, BCPS (AQ Cardiology) -- Philadelphia, PA
• Alex C. Spyropoulos, MD, FACP, FCCP -- Albuquerque, NM
• Victor F. Tapson, M.D. -- Durham, NC
• Alexander G.G. Turpie, MD, FRCP, FACP, FACC, FRCPC -- Hamilton, Ontario, Canada
• Robert T. Weibert, Pharm.D. -- San Diego, CA
• Ann K Wittkowsky, PharmD, CACP, FASHP, FCCP -- Seattle, WA